Table 2.
Variable | Value |
---|---|
Number of patients receiving maintenance TKI therapy | 89 |
Number of TKI maintenance therapies, n (%) | |
1 | 77 (87) |
>1 | 12 (13) |
Same TKI given pre-HCT and post-HCT, n (%) | |
No | 72 (81) |
Yes | 17 (19) |
TKIs used as maintenance therapy, n | |
Dasatinib | 50 |
Imatinib | 27 |
Nilotinib | 27 |